Clinical Resources
Healeon Medical is committed to advancing science and therapeutics by providing support and resources to learn more about the various technologies and therapies that are resultant from their products.
Healeon Medical's participation in sponsoring studies to help develop promising treatments and improve outcomes in a variety of applications is a large part of being a regenerative resource and one in which we take great pride in.
CURRENT STUDIES:
COVID-19 Treatment For Lung Complications
Healeon's safe and reliable CENTRIcyte 1000 system for isolating stem cells is currently involved in several studies where intravenous administration of stem cells are administered to investigate treatment outcomes for COVID-19 patients, including one from our Chief Medical Officer, Dr. Robert Alexander, for lung complications associated with COVID-19.
Here are the studies currently open or taking place:
https://clinicaltrials.gov/ct2/show/NCT04326036
https://clinicaltrials.gov/ct2/show/NCT04352803?term=Regeneris+medical&draw=2&rank=4
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2020.1761322